Yahoo Web Search

Search results

1. • Palo Alto Networks Raises the Bar Delivering the Most Comprehensive SASE Capabilities

     KTLA-TV Los Angeles· 5 hours ago

     Palo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, announced its latest innovations to future-proof and transform the workforce with the launch of Prisma® SASE 3.0. Prisma SASE ...

2. • The Top 3 Cybersecurity Stocks to Buy in April 2024

     InvestorPlace· 5 days ago

     2023 was a record year for ransomware attacks, with companies like MGM Resorts International (NYSE:MGM) suffering largely publicized attacks. The only defense will be more investments in cybersecurity ...

3. • 

     Microsoft CEO says it is "putting security above all else" in major refocus

     TechRadar via Yahoo News· 6 days ago

     Nadella highlighted ongoing efforts to enhance protection while also bolstering threat monitoring...

4. • Cybereason Announces the Availability of Cybereason Mobile Threat Defense in Response to Increases...

     PRWeb· 9 hours ago

     Organizations must increase mobile security measures to reduce the attack surface and improve visibility whilst protecting sensitive organizational data and the data

5. • Security updates from Google Cloud Next '24 center on GenAI | TechTarget

     SearchSecurity.com· 2 days ago

     A few weeks ago at Google Cloud Next '24, we saw progress on Google's generative AI vision with updates that apply GenAI across several security offerings to help solve pressing ...

6. • 3 best enterprise mobile app authentication methods | TechTarget

     SearchSecurity.com· 1 day ago

     When developing a mobile app, choose an authentication method that balances security and user experience. Dev teams should look into the different types of authentication ...

7. • 

     Arista targets lateral security threat in campus and data center networks

     Network World· 2 days ago

     Arista Networks is bolstering a key part of its security software with new features that help...

8. • Veru to Present at the GLP-1 Based Therapeutics Summit

     Morningstar· 5 hours ago

     ...controlled, randomized, dose-finding clinical trial was designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to preserve muscle and augment fat loss in approximately 90 patients with sarcopenic obesity or overweight elderly (>60 years of age)...

9. • Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

     Morningstar· 1 day ago

     Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...

10. • Q1 2024 Merit Medical Systems Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      We completed collection of safety and efficacy outcomes throughout this study follow-up period and receive primary endpoint data for the last enrolled patient during the first ...